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Fetal CD4+ lymphoid tissue inducer (LTi) cells play
a critical role in the development of lymphoid tissues.
Recent studies identified that LTi cells persist in
adults and are related to a heterogeneous population
of innate lymphoid cells that have been implicated in
inflammatory responses. However, whether LTi cells
contribute to protective immunity remains poorly
defined. We demonstrate that after infection with
Citrobacter rodentium, CD4+ LTi cells were a domi-
nant source of interleukin-22 (IL-22) early during
infection. Infection-induced CD4+ LTi cell responses
were IL-23 dependent, and ablation of IL-23 impaired
innate immunity. Further, depletion of CD4+ LTi cells
abrogated infection-induced expression of IL-22 and
antimicrobial peptides, resulting in exacerbated host
mortality. LTi cells were also found to be essential for
host protective immunity in lymphocyte-replete
hosts. Collectively these data demonstrate that adult
CD4+ LTi cells are a critical source of IL-22 and iden-
tify a previously unrecognized function for CD4+ LTi
cells in promoting innate immunity in the intestine.
INTRODUCTION
Lymphoid tissue inducer (LTi) cells are the first hematopoietic
cells recruited to the sites of secondary lymphoid tissue organo-
genesis during fetal development (Mebius et al., 1997). Produc-
tion of interleukin-7 (IL-7) and RANKL by resident stromal cells
induces LTi cell expression of lymphotoxin-a1b2 that activates
resident stromal cells to express adhesion molecules and che-
mokines that promote the formation and organization of
secondary lymphoid tissues (Mebius, 2003). The development
of LTi cells (defined as Linc-kit+CD4+CD44+CD127+CD25+
CD90+CCR6+) is dependent on the transcription factors RORgt
and Id-2, and IL-7 has been shown to regulate their survival
and function (Eberl et al., 2004; Mebius, 2003; Mebius et al.,
1997; Meier et al., 2007; Sun et al., 2000; Yokota et al., 1999).
After birth, LTi cells persist in the secondary and mucosa-
associated lymphoid tissues of adult humans and mice (Cupedo122 Immunity 34, 122–134, January 28, 2011 ª2011 Elsevier Inc.et al., 2009; Eberl and Littman, 2004; Tsuji et al., 2008). In mice,
adult CD4+ LTi cells are generated in the bone marrow and
appear to be related to an emerging category of innate lymphoid
cells (ILCs) that are phenotypically and functionally heteroge-
neous (Colonna, 2009; Cua and Tato, 2010; Kim et al., 2008;
Sawa et al., 2010; Schmutz et al., 2009; Veiga-Fernandes
et al., 2010). Although the development, lineage relationships,
and fates of adult LTi cells and other ILC populations remain to
be determined, they appear to influence immunity and inflamma-
tion in multiple settings. For example, CD4+ LTi cells promote
the maturation of tertiary lymphoid tissues after birth and the
restoration of secondary lymphoid tissues after viral infection
(Scandella et al., 2008; Tsuji et al., 2008). Additionally, an
IL-23-responsive CD4c-kitCD90+ ILC population was recently
found to express IL-17A and IFN-g and promote innate intestinal
inflammation in a murine model of colitis (Buonocore et al.,
2010). Another ILC-like population characterized by expression
of the NK cell cytotoxicity receptor NKp46 was found to express
IL-22 in response to IL-23 stimulation or after exposure to the
enteric pathogen Citrobacter rodentium and was implicated in
promoting host-protective immunity (Cella et al., 2009; Cupedo
et al., 2009; Luci et al., 2009; Sanos et al., 2009; Satoh-
Takayama et al., 2008).
Early production of IL-22 is essential for innate immunity to
enteric bacterial infection with C. rodentium, a mouse-specific
pathogen (Zheng et al., 2008). IL-22 induces expression of
antimicrobial peptides and promotes the maintenance of the
epithelial cell barrier, preventing systemic bacterial dissemina-
tion, morbidity, and host mortality (Zheng et al., 2008). Analysis
of intestinal tissues after C. rodentium infection revealed that
CD11c+ cells expressed IL-22 (Zheng et al., 2008).More recently,
an NKp46+ ILC population was found to express CD11c and
IL-22 in the small intestine after C. rodentium infection (Cella
et al., 2009; Satoh-Takayama et al., 2008). However, depletion
of a fraction of the NKp46+ ILC population, which coexpresses
NK1.1, resulted in only a modest reduction in innate immunity
to C. rodentium (Cella et al., 2009). Analysis of conventional NK
cells and NKp46+ ILCs revealed that both populations were
absent in Rag2/IL2rg/ mice, whereas only conventional NK
cells were absent in Rag2/Il2rb/ mice (Satoh-Takayama
et al., 2008). Rag2/IL2rg/ mice, but not Rag2/Il2rb/
mice, had an increased susceptibility to C. rodentium infection,
suggesting that NKp46+ ILCs and not conventional NK cells
contribute to innate antibacterial immunity (Satoh-Takayama
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LTi Cells Promote Innate Immunityet al., 2008). However, in addition to defective NKp46+ ILC devel-
opment,Rag2/Il2rg/miceexhibit impaireddevelopment and
cytokine responses in multiple innate cell populations, including
CD4+ LTi cells and other IL-22-producing ILC populations (Kim
et al., 2005; Satoh-Takayama et al., 2008; Takatori et al., 2009).
Therefore, the potential influence of adult CD4+ LTi cells versus
other IL-22-producing ILC populations on innate immunity to
bacterial infection remains to be determined.
The data in the present report demonstrate that adult CD4+ LTi
cells are the critical cell population required for early immunity to
oral infection with C. rodentium. After infection with C. roden-
tium, IL-22+ innate cells outnumbered IL-22+ adaptive immune
cells during the first 6 days of infection, and CD4+ LTi cells
were the dominant source of IL-22 after infection. A substantial
infection-induced population expansion of CD4+ LTi cells and
an increased frequency of IL-22+CD4+ LTi cells occurred in the
colon and mesenteric lymph node (mLN). Infection-induced IL-
22 production by CD4+ LTi cells was found to be IL-23 depen-
dent, and blockade of IL-23 in Rag1/ mice substantially
impaired innate immunity to C. rodentium. Furthermore, selec-
tive depletion of CD4+ LTi cells inC. rodentium-infectedRag1/
mice resulted in reduced expression of IL-22 and antimicrobial
peptides in the colon, failure to control bacterial replication and
dissemination, and more rapid host mortality. Finally, by utilizing
reconstitution of Rag1/ mice and adoptive transfer
approaches, we demonstrate that CD4+ LTi cells are critical for
the promotion of IL-22-dependent innate immunity in lympho-
cyte-replete hosts. Taken together, this report identifies adult
CD4+ LTi cells as a critical IL-23-dependent innate source of
IL-22 after enteric bacterial infection in mice and reveals a previ-
ously unrecognized function for CD4+ LTi cells in contributing to
innate immunity.
RESULTS
IL-22+ Innate Populations Outnumber IL-22+ Adaptive
Populations after C. rodentium Infection
It has been previously reported that IL-22 is necessary for immu-
nity to C. rodentium during the first 8 days of infection (Zheng
et al., 2008). However, the cellular sources of IL-22 after
C. rodentium infection remain unclear. Because IL-22 can be
expressed by a number of innate and adaptive immune cells,
C57BL/6micewere infectedwithC. rodentiumand IL-22produc-
tion was examined in innate immune cells (CD3CD5) versus
adaptive immune cells (CD3+CD5+). In naive mice (day 0) the
majority of IL-22+ cells were innate, accounting for 68% and
79% of all IL-22+ cells in the mLN and colonic intraepithelial
lymphocyte (IEL) compartment, respectively (Figures 1A and
1B). Furthermore, innate cells were the dominant IL-22+ cell pop-
ulation until day 6 and day 8 postinfection in the mLN and IEL
compartment, respectively (Figures 1A and 1B). Substantially
increased total numbers of IL-22+ innate cells compared to
IL-22+ adaptive cellswere observed at days 2 and 4postinfection
in both the mLN (Figure 1C) and IEL compartment (Figure 1D).
These data suggest that innate cells are the dominant source of
IL-22 at early time points after infection. To more thoroughly
define the temporal requirements for IL-22 in host defense to
C. rodentium, IL-22 mAb was administered to mice at different
time points after infection. All mice that received IL-22mAb start-ing onday 0 or day 2postinfection succumbed to infection byday
13 (Figure 1E). However, blockade of IL-22 starting onday4post-
infection resulted in an intermediate degree of mortality (Fig-
ure 1E). Furthermore, mice receiving IL-22 mAb beginning on
day 6 or day 8 postinfection did not succumb to C. rodentium
(Figure 1E), suggesting that IL-22 is essential for immunity to
C. rodentium during only the first 6 days of infection. Collectively,
these data demonstrate that after C. rodentium infection, innate
immune cells are the dominant sources of IL-22 production
required for early resistance to enteric bacterial infection.
Adult CD4+ LTi Cells Proliferate and Are a Dominant
Source of IL-22 after C. rodentium Infection
Several innate sources of IL-22 have previously been identified
including dendritic cells (DCs), conventional NK cells, NKp46+
ILCs,CD4 ILCs, andCD4+ LTi cells (Buonocore et al., 2010;Cella
et al., 2009; Satoh-Takayama et al., 2008; Takatori et al., 2009;
Zenewicz et al., 2008; Zheng et al., 2008). To investigate the innate
sources of IL-22 after C. rodentium infection, the frequency of
IL-22+ cells was examined in multiple cell populations in the
mLN of naive or infected mice. In comparison to naive mice,
C. rodentium-infected mice exhibited minimal changes in the
frequencyof IL-22+DCs (CD3CD5CD11c+),NKp46-expressing
cells (CD3CD5NKp46+), conventional NK cells (CD3CD5
NK1.1+), or CD4 ILCs (CD3CD5CD4CD90+Sca-1+) (Figures
2A and 2B). In contrast, analysis of the CD4+ LTi cell population
(CD3CD5CD11cCD90+CD4+) revealed an infection-induced
increase in the frequency of IL-22+ cells that was higher than other
cell populations examined (Figures2Aand2B).CD4+ LTi cells also
exhibited the highest frequency of IL-22+ cells in the IEL compart-
ment of infected mice (Figure S1A available online). Furthermore,
a comparison of IL-22 expression in CD4+ T cells versus CD4+
LTi cells in the mLN at early time points after infection with
C. rodentium revealed no increase in the frequency of
IL-22+CD4+ T cells until day 6 postinfection (Figure S1B), whereas
increases in the frequency of IL-22+CD4+ LTi cells were observed
at all early time points postinfection (Figure S1C). Collectively
these data demonstrate that CD4+ LTi cells are a dominant source
of IL-22 production early after C. rodentium infection.
Further analysis of CD4+ LTi cells (CD3CD5CD11cCD90+
CD4+) from infected mice revealed expression of c-kit, CD127
(IL-7Ra), CD25 (IL-2Ra), CCR6, and the intracellular transcription
factor RORgt (Figure 2C). To examine whether CD4+ LTi cells
were proliferating, cells from naive or infected mice were stained
for the nuclear antigen Ki-67. In comparison to naive mice, CD4+
LTi cells from the mLN or IEL compartment of infected mice ex-
hibited an increase in the frequency of Ki-67+ cells (Figure 2D),
suggesting that C. rodentium infection induced a proliferative
response of CD4+ LTi cells. Consistent with these results, signif-
icantly increased total numbers of CD4+ LTi cells were observed
in the mLN and IEL compartment of infected mice in comparison
to naive mice (Figure 2E, p < 0.01). These data demonstrate that
infection with C. rodentium induces a population expansion and
increased production of IL-22 in CD4+ LTi cells.
Infection-Induced IL-22 Production by Adult CD4+ LTi
Cells Is Dependent on IL-23
In vitro, IL-23 can induce IL-22 expression in a number of cell
types including Th17 cells, LTi cells, and other ILC populationsImmunity 34, 122–134, January 28, 2011 ª2011 Elsevier Inc. 123
Figure 1. Innate Immune Cells Are the First Population to Expand with Exposure to C. rodentium Infection and Are the Dominant Source of
IL-22 Required for Immunity
(A–D) C57BL/6 mice were infected with C. rodentium on day 0 and sacrificed on days 2, 4, 6, and 8. Cells were briefly stimulated ex vivo and the frequency of
IL-22+CD3+CD5+ cells versus IL-22+CD3CD5 cells were examined in the (A) mLN and (B) colon IEL compartment. Absolute numbers of IL-22+CD3+CD5+ cells
versus IL-22+CD3CD5 cells in the (C) mLN and (D) IEL compartment.
(E) Percent survival of IL-22 neutralizing mAb-treated and infected C57BL/6 mice. Antibody treatment was initiated on the indicated day and continued
every 3 days.
All data are representative of two independent experiments with a minimum of three mice per group or time point. Data shown are the mean ± SEM. *p < 0.05
**p < 0.01.
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LTi Cells Promote Innate Immunity(Buonocore et al., 2010; Cella et al., 2009; Liang et al., 2006;
Satoh-Takayama et al., 2008; Takatori et al., 2009). To test
whether in vivo infection-induced IL-22 production from
CD4+ LTi cells was IL-23 dependent, Il23a+/+ and Il23a/
mice were infected with C. rodentium and the CD4+ LTi cell
response was examined by flow cytometry. Naive Il23a+/+
versus Il23a/ mice displayed similar basal frequencies of
CD4+ LTi cells (Figure 3A, top) and IL-22+CD4+ LTi cells in
the mLN (Figure 3B, top). However, infection-induced
increases in the frequency of CD4+ LTi cells in the mLN of in-
fected Il23a+/+ mice were not observed in infected Il23a/
mice (Figure 3A, bottom). Infection with C. rodentium
resulted in an increase in the frequencies of IL-22+CD4+ LTi
cells in Il23a+/+ mice (Figure 3B, left) that was not observed
in infected Il23a/ mice (Figure 3B, right), demonstrating
that infection-induced CD4+ LTi cell-derived IL-22 responses124 Immunity 34, 122–134, January 28, 2011 ª2011 Elsevier Inc.are predominantly IL-23 dependent. Consistent with IL-23-
dependent IL-22 production in innate cells, further examination
of the innate lymphoid compartment revealed that stimulation
of splenocytes from naive Rag1/ mice with rIL-23 resulted in
an increased frequency of IL-22+ cells compared to cells
cultured in media alone (Figure 3C). Phenotypic analysis of
IL-22+ cells from rIL-23-stimulated cultures revealed that the
majority coexpressed CD90 and CD4 (Figure 3D). The IL-22+
innate cells were confirmed to be CD4+ LTi cells because
this population coexpressed c-kit, CD127 (IL-7Ra), CD25 (IL-
2Ra), CCR6, and the intracellular transcription factor RORgt
(Figure 3E). The non-CD4+IL-22+ cells in spleen cultures
most closely resembled CD4 LTi cells in that they also ex-
pressed c-kit and CD90 but lacked expression of NK1.1,
NKp46, and CD11c (Figure S2A). CD4+ LTi cells were also
the dominant source of IL-23-induced IL-22 in innate cells
Figure 2. Adult CD4+ LTi Cells Expand and Are a Dominant Innate Source of IL-22 after C. rodentium Infection
(A and B) C57BL/6 mice were infected with C. rodentium on day 0 and sacrificed on day 4. Frequency of ex vivo stimulated IL-22+ innate cells in the mLN of (A)
naive and (B) infected mice gated as indicated for various surface markers.
(C) The gated CD3CD5CD11cCD90+CD4+ population in the mLN of C. rodentium-infected mice was stained with c-kit, CD127, CD25, CCR6, and RORgt
antibodies (bold black line) and corresponding isotype and negative control antibodies (solid gray histograms).
(D and E) C57BL/6 mice were infected with C. rodentium on day 0 and sacrificed on day 8.
(D) Frequency of Ki-67+CD4+ LTi cells (CD3CD5CD11cCD90+CD4+) in the mLN and IEL compartment.
(E) Absolute numbers of CD4+ LTi cells in the mLN and IEL compartment of naive (N) and infected (INF) mice.
All data are representative of two or more independent experiments with a minimum of three to four mice per group. Data shown are the mean ± SEM. **p < 0.01.
See Figure S1 for additional data.
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LTi Cells Promote Innate Immunityisolated from the IEL compartment (Figure S2B). Examination
of sorted CD4+ LTi cells (Figure 3F) revealed a mononuclear
morphology (Figure S3C) and significant elevated expressionof mRNA encoding Id2 (Figure 3G, p < 0.05) and Il23r (Fig-
ure 3H, p < 0.05). Sorted CD4+ LTi cells secreted increased
amounts of IL-22 protein after stimulation with rIL-23Immunity 34, 122–134, January 28, 2011 ª2011 Elsevier Inc. 125
Figure 3. Citrobacter rodentium-Induced
Adult CD4+ LTi Cell Responses Are Depen-
dent on IL-23
Il23a+/+ and Il23a/ mice were infected with
C. rodentium on day 0 and sacrificed on day 8.
(A) Frequency of CD4+ LTi cells in themLN of naive
and infected mice. Populations are gated on live
CD3CD5CD90+CD4+ cells.
(B) Frequency of ex vivo stimulated IL-22+CD4+
LTi cells in the mLN. Populations are gated on
live CD3CD5CD90+CD4+ cells.
All data are representative of two ormore indepen-
dent experiments with a minimum of three to four
mice per group. Naive Rag1/ mouse spleno-
cytes were cultured overnight with or without
rIL-23.
(C) Frequency of IL-22+ cells with gating on live
cells.
(D) Frequency of CD90+CD4+ cells in the IL-22+
gated population of (C).
(E) The IL-22+CD90+CD4+ population of (D) was
stained with c-kit, CD127, CD25, CCR6, and
RORgt antibodies (bold black lines) and corre-
sponding isotype and negative control antibodies
(solid gray histograms).
(F) CD4+ LTi cells were purified from naiveRag1/
splenocytes and stained with CD4, CD11c, and
B220 antibodies.
(G and H) Fold induction of (G) Id2 and (H) Il23r
mRNA in purified CD4+ LTi cells relative to total un-
fractionated Rag1/ splenocytes (SPL).
(I) IL-22 protein in culture supernatants from puri-
fied CD4+ LTi cells stimulated in the presence or
absence of rIL-23.
All in vitro data are representative of two or more
independent experiments with a minimum of two
to three replicate wells. Data shown are the
mean ± SEM. *p < 0.05, **p < 0.01. See Figure S2
for additional data.
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LTi Cells Promote Innate Immunity(Figure 3I), demonstrating that IL-23 could directly induce
IL-22 expression in CD4+ LTi cells. Collectively these data
indicate that CD4+ LTi cells are a dominant IL-23-responsive,
IL-22-producing innate cell population, and that in vivo
infection-induced CD4+ LTi cell responses are regulated by
IL-23.
Innate Immunity to Citrobacter rodentium Is Dependent
on IL-23
After C. rodentium infection, Il23a/ mice exhibit elevated
bacterial loads and succumb to infection (Mangan et al.,
2006), and it has been proposed that this defective immunity
may be the result of impaired Th17 cell effector responses
observed in the absence of IL-23 (McGeachy et al., 2009).
However, whether IL-23 is required for innate immunity to
C. rodentium has not been examined. To test the role of IL-23
in innate immunity to C. rodentium, Rag1/ mice were infected
and administered either isotype control or IL-23p19 mAb. Exam-126 Immunity 34, 122–134, January 28, 2011 ª2011 Elsevier Inc.ination of the colonic tissue after infection
revealed that isotype mAb-treated
Rag1/ mice exhibited an increase in
Il22 mRNA (Figure 4A) and IL-22 protein(Figure 4B) over naive Rag1/ mice. Administration of multiple
doses of IL-23p19 mAb to infected Rag1/ mice reduced both
intestinal Il22 transcript (Figure 4A) and IL-22 protein (Figure 4B)
in comparison to isotype-treated and infected Rag1/ mice.
Consistent with a decrease in IL-22 expression, infected
Rag1/ mice administered IL-23p19 mAb also exhibited
reduced mRNA encoding the IL-22-dependent antimicrobial
peptides RegIIIb and RegIIIg in the colon (Figure 4C). Further-
more, IL-23p19 mAb-treated Rag1/ mice displayed an
increase in fecal colony forming units (CFU) at day 10 postinfec-
tion compared to isotype control mAb (Figure 4D). Reduced
expression of IL-22 and lower amounts of antimicrobial peptides
in the colon have previously been reported to result in systemic
dissemination of C. rodentium to peripheral tissues resulting in
substantial tissue inflammation, morbidity, and mortality (Zheng
et al., 2008). Consistent with this, in comparison to isotype mAb
treatment, IL-23p19 mAb treatment of Rag1/ mice resulted in
increased CFU of C. rodentium in the liver (Figure 4E), increased
Figure 4. Innate Immunity to Citrobacter rodentium Is Dependent on IL-23
C57BL/6Rag1/were administered an isotype control mAb or an IL-23p19mAb starting on day 0, infected withC. rodentium on day 0, and sacrificed on day 10.
(A) Fold induction of Il22 transcript in colonic RNA from antibody-treated and infected (INF) mice compared to naive mice.
(B and C) IL-22 protein in the supernatant of colon homogenates (B) and fold induction of Reg3b and Reg3g transcript in colonic RNA (C) from antibody-treated
and infected mice compared to naive mice.
(D and E) C. rodentium CFU in the (D) fecal pellets and (E) liver of antibody-treated and infected mice.
(F) H&E-stained histological sections of the liver of antibody-treated and infected mice; inflammatory cell infiltrates (black arrows) and necrotic lesions (white
arrow). Scale bars represent 100 mm.
(G–I) Serum ALT levels (G), percent of original whole body weight (H), and percent survival (I) of antibody-treated and infected mice.
All data are representative of three or more independent experiments with a minimum of three to four mice per group. Data shown are the mean ± SEM. *p < 0.05,
**p < 0.01, ***p < 0.001.
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LTi Cells Promote Innate Immunityinflammatory cell infiltrates (black arrows, Figure 4F), and the
appearance of necrotic lesions in the liver (white arrow, Fig-
ure 4F). IL-23p19 mAb treatment also resulted in elevated
amounts of the liver enzyme alanine transaminase (ALT) in
comparison to isotype mAb treatment (Figure 4G), indicative
of increased liver damage. Finally, in comparison to Rag1/
mice receiving an isotype mAb treatment, those receiving an
IL-23p19 mAb treatment exhibited an increased rate of weight
loss (Figure 4H) and succumbed to infection at earlier time
points (Figure 4I). These data demonstrate that CD4+ LTi cell
responses and innate immunity to C. rodentium are IL-23
dependent.Depletion of Adult CD4+ LTi Cells Substantially Impairs
Innate Immunity to C. rodentium
To test the contribution of adult CD4+ LTi cells to innate immu-
nity in the gut, CD90 mAb was administered to infected
Rag1/ mice. CD90 mAb treatment resulted in efficient deple-
tion of CD4+ LTi cells in comparison to isotype mAb treatment
(Figure 5A). Despite complete depletion of CD4+ LTi cells, anal-
ysis of cells expressing NK cell receptors revealed that CD90
mAb administration did not result in substantial changes in
the frequency of NK1.1+ cells in the spleen (Figures S3A and
S3B) or NKp46+ cells in the IEL compartment (Figure S3C).
Rag1/ mice receiving mAb treatments were analyzed forImmunity 34, 122–134, January 28, 2011 ª2011 Elsevier Inc. 127
Figure 5. CD90 mAb Treatment Impairs Innate Immunity to Citrobacter rodentium
C57BL/6 Rag1/ were administered an isotype control mAb or an CD90 mAb starting on day 0, infected with C. rodentium on day 0, and sacrificed at day 10.
(A) Frequency of CD4+CD90+ cells in Lin gated splenocytes from antibody-treated Rag1/ mice.
(B) Fold induction of Il22 transcript in colonic RNA from antibody-treated and infected (INF) mice compared to naive mice.
(C and D) IL-22 protein in the supernatant of colon homogenates (C) and fold induction of Reg3b and Reg3g transcript in colonic RNA (D) from antibody-treated
and infected mice compared to naive mice.
(E and F) C. rodentium CFU in the (E) fecal pellets and (F) liver of antibody-treated and infected mice.
(G) H&E-stained histological sections of the liver of antibody-treated and infected mice; inflammatory cell infiltrates (black arrows) and necrotic lesions
(white arrow). Scale bars represent 100 mm.
(H–J) Serum ALT levels (H), percent of original whole body weight (I), and percent survival (J) of antibody-treated and infected mice.
All data are representative of three or more independent experiments with a minimum of three to four mice per group. Data shown are the mean ± SEM. *p < 0.05,
**p < 0.01, ***p < 0.001. See Figure S3 for additional data.
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LTi Cells Promote Innate Immunityinnate immunity to C. rodentium. Infection-induced increases in
both Il22 mRNA (Figure 5B) and IL-22 protein (Figure 5C) were
reduced in colon tissue of Rag1/ mice that received CD90
mAb in comparison to isotype mAb treatment. The reduction
of IL-22 expression in CD90 mAb-treated Rag1/ mice also
correlated with a reduction in colonic mRNA for the genes en-
coding RegIIIb and RegIIIg (Figure 5D). Furthermore, examina-
tion of fecal burdens revealed that CD90 mAb-treated Rag1/
mice exhibited higher C. rodentium CFU compared to control
treated mice (Figure 5E), increased dissemination of bacteria
to the liver (Figure 5F), and augmented liver pathology charac-
terized by increased inflammatory infiltrates (Figure 5G, black128 Immunity 34, 122–134, January 28, 2011 ª2011 Elsevier Inc.arrows) and liver necrosis (Figure 5G, white arrow) in compar-
ison to isotype mAb-treated mice. Finally, similar to IL-23p19
mAb-treated Rag1/ mice, those treated with CD90 mAb ex-
hibited increased serum concentrations of ALT (Figure 5H), an
elevated rate of weight loss (Figure 5I), and decreased survival
in comparison to isotype mAb-treated Rag1/mice (Figure 5J).
Taken together, these results demonstrate that depletion of
CD90+ cells in Rag1/ mice impairs IL-22 production and
substantially reduces innate resistance to C. rodentium.
CD90 mAb administration depletes both CD4+ and CD4
innate cell populations (Figure 5A), including an IL-22-expressing
c-kitCD4 ILC population that was recently reported to
Figure 6. Adult CD4+ LTi Cells Mediate Innate Immunity to Citrobacter rodentium
C57BL/6 Rag1/ were administered an isotype control mAb or CD4 mAb starting on day 0, infected with C. rodentium on day 0, and sacrificed at day 10.
(A) Frequency of CD4+CD90+ cells in Lin gated splenocytes from antibody-treated Rag1/ mice.
(B) Fold induction of Il22 transcript in colonic RNA from antibody-treated and infected (INF) mice compared to naive mice.
(C and D) IL-22 protein in the supernatant of colon homogenates (C) and fold induction of Reg3b and Reg3g transcript in colonic RNA (D) from antibody-treated
and infected mice compared to naive mice.
(E and F) C. rodentium CFU in the (E) fecal pellets and (F) liver of antibody-treated and infected mice.
(G) H&E-stained histological sections of the liver of antibody-treated and infected mice; inflammatory cell infiltrates (black arrows) and necrotic lesions
(white arrow). Scale bars represent 100 mm.
(H–J) Serum ALT levels (H), percent of original whole body weight (I), and percent survival (J) of antibody-treated and infected mice.
All data are representative of three or more independent experiments with a minimum of three to four mice per group. Data shown are the mean ± SEM. *p < 0.05,
**p < 0.01, ***p < 0.001.
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LTi Cells Promote Innate Immunitycontribute to intestinal inflammation (Buonocore et al., 2010).
Therefore, to examine whether the CD90 mAb-mediated loss in
innate immunity to C. rodentium was due to depletion of the
CD4+ LTi cells or of the CD4 ILCs, infected Rag1/ mice
were treated with either control or CD4 mAb. Examination of
spleens from mAb-treated mice revealed that CD4+ LTi cells,
but not CD4CD90+ cells, were successfully depleted after
administration of CD4 mAb in comparison to isotype mAb-
treated mice (Figure 6A). Similar to CD90 mAb administration,
CD4 mAb administration did not result in substantial changes
in the frequency of NK1.1+ cells in the spleen (Figure S3B) or
NKp46+ cells in the IEL compartment (Figure S3C). Treatmentof infected Rag1/ mice with CD4 mAb also abrogated
C. rodentium infection-induced increases in both colonic Il22
mRNA (Figure 6B) and IL-22 protein (Figure 6C) in comparison
to isotype mAb treatment. In addition, CD4 mAb-treated
Rag1/ mice demonstrated a reduction in colonic mRNA for
genes encoding RegIIIb and RegIIIg after infection (Figure 6D).
Analysis of fecal burdens demonstrated that CD4 mAb-treated
Rag1/ mice exhibited higher C. rodentium CFU (Figure 6E).
Bacterial dissemination was also evident in CD4-depleted
Rag1/ mice in that higher bacterial burdens were found in
the liver (Figure 6F), in addition to an observed increase in inflam-
matory infiltrates (Figure 6G, black arrows) and necrosisImmunity 34, 122–134, January 28, 2011 ª2011 Elsevier Inc. 129
Figure 7. Adult CD4+ LTi Cells Are Neces-
sary andSufficient to Promote Innate Immu-
nity to C. rodentium-Infected Lymphocyte-
Replete Hosts
(A) Representative flow cytometry plots demon-
strating depletion of recipient CD4+ LTi cells but
not donor CD4+ T cells in CD90.2 mAb-treated
chimeras in comparison to isotype mAb-treated
chimeras.
(B) Percent survival of isotype and CD90.2 mAb-
treated and infected (INF) mice. Displayed data
are from two independent experiments with three
mice per group per experiment.
(C) Representative flow cytometry plots demon-
strating purity of transferred populations.
(D) Percent survival of antibody-treated and in-
fected (INF) mice. Displayed data are from two
independent experiments with twomice per group
per experiment.
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LTi Cells Promote Innate Immunity(Figure 6G, white arrow). Finally, Rag1/mice treated with CD4
mAb exhibited increased serum concentrations of ALT (Fig-
ure 6H), exaggerated weight loss (Figure 6I), and increased
rate of mortality in comparison to isotype mAb-treated Rag1/
mice (Figure 6J). A similar defect in innate immunity was previ-
ously observed inRag2/Il2rg/mice and attributed to defects
in NKp46+ ILC populations (Satoh-Takayama et al., 2008).
However, given that this population is reported to lack CD4
expression (Satoh-Takayama et al., 2008) andwe do not observe
a decrease in the frequency of NKp46+ populations after CD4
mAb administration (Figure S3C), our collective observations130 Immunity 34, 122–134, January 28, 2011 ª2011 Elsevier Inc.from the effect of CD90 or CD4 mAb
administration suggest that defective
innate immunity to C. rodentium
observed in Rag2/IL2rg/ mice may
be attributed to defects in adult CD4+
LTi cell responses. Notwithstanding this,
these data collectively indicate that
CD4+ LTi cells are a critical innate source
of IL-22 after infection and directly
contribute to innate immunity to enteric
bacterial infection.
CD4+ LTi Cells Promote Essential
Innate Immunity in Lymphocyte-
Replete Hosts
To test whether CD4+ LTi cells can
promote innate immunity in a lympho-
cyte-replete host, two model systems
were utilized. First, Rag1/ mice ex-
pressing the CD90.2 allele were reconsti-
tuted with purified T cells (CD3+) and B
cells (CD19+) from a C57BL/6 mouse ex-
pressing the CD90.1 allele. Gating on
splenic CD4+ cells in an isotype mAb-
treated CD90-disparate chimera re-
vealed a population of donor
CD90.2CD3+CD5+CD4+ T cells and
a population of recipient CD90.2+-CD3CD5CD4+ LTi cells (Figure 7A). Administration of
CD90.2 mAb to the chimeras revealed a selective depletion of
recipient CD4+ LTi cells but not donor CD4+ T cells (Figure 7A),
thus providing an in vivo model to interrogate LTi cell function
in lymphocyte-replete hosts. CD90-disparate chimeras and
unreconstituted Rag1/ mice were infected with C. rodentium
and treated with an isotype mAb or CD90.2 mAb. As observed
previously, Rag1/ mice receiving an isotype mAb survived
for approximately 26 days postinfection, whereas Rag1/
mice receiving a CD90.2 mAb succumbed to infection around
day 12 (Figure 7B). In contrast, although 66% of isotype
Immunity
LTi Cells Promote Innate ImmunitymAb-treatedRag1/ chimeras did not succumb to infection and
survived longer than isotype mAb-treated Rag1/ mice, 100%
of LTi cell-depleted CD90.2 mAb-treated Rag1/ chimeras
succumbed to infection at early time points despite the presence
of donor lymphocytes (Figures 7A and 7B). These data suggest
that adaptive immunity is required for protection to C. rodentium
at late time points but that LTi cells are required for innate
immunity at early time points in a lymphocyte-replete host.
We next investigated whether CD4+ LTi cells are sufficient to
provide innate immunity toC. rodentium in a lymphocyte-replete
host. Il22+/+ and Il22/ mice were infected with C. rodentium
and on days 2, 3, and 4 postinfection, 1 3 106 CD4+ T cells or
1.5 3 103 CD4+ LTi cells from Il22+/+ hosts were purified and
adoptively transferred into infected Il22/ hosts (Figure 7C).
Analysis of host mortality revealed that, consistent with a previ-
ously published study (Zheng et al., 2008), 100% of C. roden-
tium-infected Il22/ mice succumbed to infection at early time
points (Figure 7D). All infected Il22/ mice receiving Il22+/+
CD4+ T cells also succumbed to infection at early time points.
However, 50% of Il22/ mice receiving Il22+/+ CD4+ LTi cells
survived infection beyond day 20 (Figure 7D). Collectively, these
studies indicate that CD4+ LTi cells play a critical role in innate
immunity in the intestine of lymphocyte-replete hosts.
DISCUSSION
In this study we demonstrate that after infection with the enteric
rodent pathogen C. rodentium, adult CD4+ LTi cells proliferate
and upregulate IL-22 production within the first 6 days postinfec-
tion. CD4+ LTi cells were found to be the dominant source of
IL-22, and infection-induced CD4+ LTi cell responses were
predominantly IL-23 dependent. Furthermore, this report
demonstrates that IL-23 is critical in mediating innate immunity
to C. rodentium in mice. Consistent with being a dominant
source of infection-induced IL-22, depletion of CD4+ LTi cells
in C. rodentium-infected Rag1/mice resulted in an abrogation
of infection-induced IL-22 and antimicrobial peptide expression,
enhanced bacterial replication and dissemination, and exacer-
bated host morbidity and mortality. Furthermore, in lympho-
cyte-replete hosts, CD4+ LTi cells were found to be critical in
promoting innate immunity in the intestine.
Previous studies examining the function of adult CD4+ LTi cells
revealed that they have the capacity to promote lymphoid-tissue
organogenesis and the maintenance of lymphoid tissue archi-
tecture after CD8+ T cell-mediated lysis of virally infected
resident stromal organizer cells (Scandella et al., 2008; Schmutz
et al., 2009). These studies provoke the hypothesis that the func-
tion of CD4+ LTi cells in adults might be to promote lymphoid
tissuemaintenance and tertiary lymphoid tissue formation. Other
studies have demonstrated that LTi cells in adult mice and
humans constitutively express RORgt and have the capacity to
express IL-22 in vitro (Eberl and Littman, 2004; Takatori et al.,
2009). Because IL-22 has been found to play important roles in
promoting inflammation, tissue protection, and/or protective
immunity (Sonnenberg et al., 2010a, 2010b; Zenewicz et al.,
2008; Zheng et al., 2007, 2008), this provokes the hypothesis
that the role of CD4+ LTi cells in adults may extend beyond
lymphoid tissue generation and maintenance. Consistent with
this, LTi cells are now being classified in an emerging categoryof ILCs, in which all members share a developmental require-
ment for RORgt, and several ILC populations have been impli-
cated in promoting innate immunity and intestinal inflammation
via production of host protective and/or inflammatory cytokines
(Buonocore et al., 2010; Cella et al., 2009; Colonna, 2009; Cua
and Tato, 2010; Eberl et al., 2004; Satoh-Takayama et al.,
2008; Sawa et al., 2010; Spits and Di Santo, 2010). For example,
a population of c-kitCD4 ILCs has recently been suggested to
promote intestinal inflammation through production of IL-17A
and IFN-g (Buonocore et al., 2010). Further, a population of
NKp46+ ILCs was implicated in promoting innate immunity to
C. rodentium (Cella et al., 2009; Satoh-Takayama et al., 2008);
however, loss-of-function and gain-of-function experiments
were difficult to interpret because of the lack of specific reagents
to deplete this cell population. In contrast to these studies, we
now demonstrate that CD4+ LTi cells proliferate and are the
dominant source of IL-22 duringC. rodentium infection. Through
loss-of-function and gain-of-function approaches we provide
evidence that CD4+ LTi cells are critical for promoting infec-
tion-induced increases in antimicrobial peptide expression,
controlling bacterial replication and dissemination, and protect-
ing from host morbidity and mortality. Collectively these data
identify a previously unrecognized role for CD4+ LTi cells in
innate immunity to enteric bacterial infection.
The regulatory signals that influence LTi cell and ILC function
are poorly defined. Recently it has been shown that IL-23 can
promote innate cell-driven colitis and that IL-23 can promote
ILC production of IL-22, IL-17A, and IFN-g in vitro (Buonocore
et al., 2010; Cella et al., 2009; Satoh-Takayama et al., 2008;
Takatori et al., 2009; Uhlig et al., 2006). IL-23 has previously
been found to be necessary for immunity to C. rodentium in
wild-type mice (Mangan et al., 2006; Zheng et al., 2008);
however, the impaired resistance to infection was thought to
be due to defective generation and/or maintenance of CD4+
Th17 cells. Here, we demonstrate that IL-23 promotes infec-
tion-induced expression of IL-22 in CD4+ LTi cells and is essen-
tial for innate immunity to enteric bacterial infection in vivo.
These data provide evidence that CD4+ LTi cells are critical for
innate immunity in the lymphopenic environment of a Rag1/
mouse, and these findings may have important clinical implica-
tions. For example, several clinical conditions in patients are
characterized by the development of severe lymphopenia,
including AIDS, cancer, and tissue transplantation, and a leading
cause of mortality in these patients is secondary bacterial
infections at mucosal sites (Bonnet et al., 2007; Douek et al.,
2003; Lewden et al., 2008; Segel et al., 2003; Storek et al.,
1997; Wallace et al., 1993; Zitvogel et al., 2008). The ability to
specifically target and promote LTi cell-dependent innate immu-
nity with novel immunotherapies could be beneficial in managing
these conditions. Thus, these studies and future investigations
on the development and regulation of both CD4+ LTi cells and
innate immunity to enteric bacterial infections in lymphocyte-
deficient mice could be of substantial value in the design of
new intervention strategies for these human conditions.
Notwithstanding this, it is important to consider the potential
functions of CD4+ LTi cells in promoting innate immunity in
lymphocyte-replete hosts. Employing CD90-disparate chimeras
and adoptive transfer approaches, we report that CD4+ LTi cells
are necessary and sufficient to partially restore innate immunityImmunity 34, 122–134, January 28, 2011 ª2011 Elsevier Inc. 131
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lymphocyte-replete hosts. This was surprising given that CD4+
T cells outnumber CD4+ LTi cells in vivo. However, it is consistent
with data that CD4+ LTi cells are the dominant source of IL-22
early during infection, whereas infection-induced T cell-derived
IL-22 is not detectable until time points when IL-22 is no longer
required for immunity to infection. Therefore, CD4+ LTi cells
appear to be sentinel innate cells at mucosal sites, which repre-
sent an essential early source of IL-22. CD4+ T cells and B cells
are also required for immunity to Citrobacter, yet appear to be
critical at later time points because mice deficient in these cells
survive for several weeks postinfection (Simmons et al., 2003).
Collectively, these data provoke a model in which CD4+ LTi cells
expand and produce IL-22 to control early enteric bacterial infec-
tion until a sufficient adaptive immune response can be initiated
to effectively clear the pathogen.
All ILC populations require RORgt for their development (Buo-
nocore et al., 2010; Eberl et al., 2004; Sanos et al., 2009), and
RORgt has been suggested to regulate expression of IL-23R in
CD4+ T cells (Ivanov et al., 2006; Zhou et al., 2007). The develop-
ment of ILC populations may render them constitutively respon-
sive to IL-23-mediated signals, suggesting that IL-23 may repre-
sent a conserved pathway that stimulates innate cell cytokine
responses to promote either intestinal inflammation (Buonocore
et al., 2010) or innatehost defenseafter entericbacterial infection.
Therefore, in addition to influencing adaptive immune responses
through the induction and maintenance of secondary lymphoid
tissues, CD4+ LTi cells also influence innate immune responses
through the production of host-protective cytokines, increasing
IL-22-dependent expression of antimicrobial peptides and
promoting innate immunity. Cellular immunity evolved prior to
organized secondary lymphoid tissues (Burnet, 1968), and it
has been proposed that LTi cells may represent a primitive form
of cellular immunity (Kim et al., 2009; Lane et al., 2008). Given
that these data demonstrate that CD4+ LTi cells promote innate
immunity, it is likely that host-protective functions of CD4+ LTi
cells evolutionarily preceded the acquisition of lymphoid tissue-
inducing functions and that CD4+ LTi cells represent an ancient
precursor to more elaborate forms of cellular antibacterial immu-
nity. Collectively these data provide insights into the evolution of
the IL-23-Th17 cell axis in the context of inflammation and immu-
nity at mucosal sites. Moreover, the identification of a role for
CD4+ LTi cells in lymphopenic and lymphocyte-replete hosts
highlights the potential to target this cell population in promoting
innate immunity and efficacy of vaccination while limiting debili-
tating chronic inflammation at mucosal sites.EXPERIMENTAL PROCEDURES
Mice and Use of Monoclonal Antibodies In Vivo
C57BL/6, C57BL/6 Rag1/, and C57BL/6 CD90.1 mice were purchased from
the Jackson Laboratory (Bar Harbor, ME). Il23a/ mice on a C57BL/6 back-
ground were generated by Lexicon Pharmaceuticals, Inc. (The Woodlands,
TX) and were provided by M.M.E. (Centocor, Radnor, PA). 129 Il22/ mice
were generated at Lexicon Genetics in collaboration with Pfizer and subse-
quently backcrossed to Balb/cBy at the Jackson Laboratory with colony
mates used for all groups. All mice were maintained in specific pathogen-
free facilities at the University of Pennsylvania. All protocols were approved
by the University of Pennsylvania Institutional Animal Care and Use Committee
(IACUC), and all experiments were performed according to the guidelines of132 Immunity 34, 122–134, January 28, 2011 ª2011 Elsevier Inc.the University of Pennsylvania IACUC. Generation of the IL-23p19 mAb
(CNTO 6163) was previously described (Fitch et al., 2009). CD4 mAb (GK1.5)
was purified from ascites and CD90.2 mAb (30H12) was purchased from Bio-
XCell (West Lebanon, NH). IL-22 mAb (IL22-01) was provided by Pfizer. All
mAb treatments were administered i.p. every 3 days at a dose of 250 mg/
mouse starting on day 0 of infection or the designated day postinfection.Citrobacter rodentium Infection and Assessment of CFU
Citrobacter rodentium (formerly Citrobacter freundii, biotype 4280) strain
DBS100 (provided by B. Vallance, University of British Columbia, Vancouver,
British Columbia, Canada) was prepared by selecting a single colony and
culturing in LB broth overnight. Mice were inoculated with approximately
1 3 1010 CFU in 200 ml via oral gavage. Analysis of CFU from overnight
cultures, mechanically homogenized fecal pellets, or mechanically homoge-
nized livers were determined via serial dilutions on MacConkey’s agar.Isolation of Cells and Flow Cytometric Analysis
Spleens andmLNswere harvested and single-cell suspensions were prepared
at necropsy. For IEL isolation, colons were isolated, attached fat removed, and
tissues cut open longitudinally. Luminal contents were removed by shaking in
cold PBS and tissue was cut into 1–2 cm pieces and washed in RPMI contain-
ing 5% FCS. Epithelial cells were removed by incubating tissue in stripping
buffer (1 mMEDTA, 1mMDTT, and 5%FCS) for 10min at 37C. The remaining
tissue was then incubated for an additional 20 min in stripping buffer to collect
leukocytes from the IEL compartment.
For flow cytometric analysis, cells were stained with antibodies to the
following markers: TCRb, CD5, CD3 (conjugated to PE-Cy7, eBioscience),
CD19, Sca-1 (conjugated to PerCP-Cy5.5, eBioscience), CD4 (conjugated
to PE-Texas Red, Invitrogen), CD90.2 (conjugated to Alexa Fluor-700, Biole-
gend), CD11c, B220 (conjugated to APC-eFluor780, eBioscience) c-kit,
CD127, CD25, NKp46 (conjugated to FITC, eBioscience), NK1.1 (conjugated
to PE, eBioscience), and CCR6 (conjugated to PE, R&D Systems). For intra-
cellular staining of transcription factors, cells were fixed and permeabilized
via a commercially available kit (eBioscience) and stained with an antibody
to RORgt (conjugated to PE, eBioscience). For cytokine production, cells
were stimulated directly ex vivo by incubation for 4 hr with 50 ng/mL PMA,
750 ng/mL ionomycin, 10 mg/mL Brefeldin A (all obtained from Sigma-
Aldrich), and 10 ng/mL rIL-23 (eBioscience). Cells were fixed and permeabi-
lized as indicated above and stained with IL22-02 (Pfizer) conjugated to Alexa
Fluor 647 according to manufacturer’s instructions (Molecular Probes). Dead
cells were excluded from analysis by means of a violet viability stain (Invitro-
gen). Flow cytometry data collection was performed on a FACSCanto II (BD
Biosciences). Files were analyzed with FlowJo software (Tree Star Inc.). CD4+
LTi cells were sorted from naive Rag1/ splenocytes by excluding cells
positive for the lineage markers CD11c, B220 (conjugated to APC-eFluor-
780, eBioscience), Gr-1, NK1.1, and NKp46 (conjugated to FITC, eBio-
science) and gating for CD90+CD4+ cells on a FACSAria (BD Bioscience).
Cytocentrifuge preparations of sorted cells were stained with H&E (Thermo
Fisher Scientific).In Vitro Cell Stimulations
Total Rag1/ splenocytes or total Rag1/ IELs were cultured overnight in the
presence or absence of 10 ng/mL rIL-23 (eBioscience). Cells were then stim-
ulated for 4 hr with 50 ng/mL PMA, 750 ng/mL ionomycin, and 10 mg/mL Bre-
feldin A for analysis of intracellular cytokine production as described above.
Sorted CD4+ LTi cells from Rag1/ splenocytes were cultured for 72 hr in
complete media containing 10 ng/mL rIL-7 (Peprotech) to enhance survival
in the presence or absence of rIL-23 10 ng/mL for analysis of IL-22 secretion
from cell-free supernatants.ELISA
Tissue from the terminal colon was mechanically homogenized in PBS and
centrifuged and the resultant supernatant was measured for IL-22 protein by
sandwich ELISA with IL22-01 (Pfizer) as a capture antibody and biotin-conju-
gated IL22-03 (Pfizer) as a detection antibody.
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Blood from infected animals was obtained, allowed to clot, and centrifuged to
obtain serum. Serum ALT was measured with a commercially available kit
according to manufacturer’s directions (Biotron Diagnostics Inc., Hemet,
CA) adapted to a 96-well plate format.Quantitative Real-Time PCR
RNA was isolated from colon tissue with mechanical homogenization and
TRIzol (Invitrogen). RNA from sorted populations was isolated with RNeasy
mini kits (QIAGEN). cDNA was generated with Superscript reverse transcrip-
tion (Invitrogen). Real-time PCR (RT-PCR) was performed on cDNA with
SYBR green chemistry (Applied Biosystems) and commercially available
primer sets (QIAGEN). Reactions were run on a real-time PCR system
(ABI7500; Applied Biosystems). Samples were normalized to b-actin and dis-
played as a fold induction over naive controls unless otherwise stated.Histological Sections
Livers were fixed with 4% paraformaldehyde and embedded in paraffin, and
5 mm sections were used for staining with H&E.CD90-Disparate Rag1–/– Chimeras and Il22–/– Adoptive Transfers
Cells from mLN and spleen of CD90.1 C57BL/6 mice were obtained and
approximately 60–80 3 106 sort purified B (CD19+) and T (CD3+CD5+) cells
were transferred i.v. to CD90.2 Rag1/ mice. Reconstitution was permitted
for 8–10 weeks posttransfer and subsequently confirmed by examination of
peripheral blood lymphocytes.
C. rodentium-infected Il22+/+mice were sacrificed on days 2, 3, and 4 post-
infection, and approximately 1 3 106 CD4+ T cells (CD4+CD3+CD5+) or 1.5 3
103 CD4+ LTi cells (CD4+CD3CD5) from the spleen and mLN were sort puri-
fied and briefly stimulated for 1–2 hr in vitro with 10 ng/mL rIL-23 and 10 ng/mL
IL-1b (eBioscience). Cells were then transferred i.v. into coinfected Il22/
mice.Statistical Analysis
Results represent the mean ± SEM. Statistical significance was determined by
the Student’s t test unless otherwise stated. For survival curves, significance
was determined with the log rank (Mantel-Cox) test. *p < 0.05; **p < 0.01;
***p < 0.001.SUPPLEMENTAL INFORMATION
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